Next Article in Journal
Mathematical Evaluation of the Amino Acid and Polyphenol Content and Antioxidant Activities of Fruits from Different Apricot Cultivars
Previous Article in Journal
Antioxidant Capacity of Ocimum basilicum L. and Origanum vulgare L. Extracts
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Acute Toxicity and Hepatotoxicokinetic Studies of Tamarindus indica Extract

1
Applied and Environmental Microbiology Research Group, Department of Biochemistry and Microbiology, University of Fort Hare, Private Bag 1314, Alice, 5700 Eastern Cape, South Africa
2
Department of Veterinary Medicine, University of Nigeria, Nsukka, 410002, Enugu State, Nigeria
3
Department of Veterinary Physiology and Pharmacology, University of Nigeria, Nsukka, 410002, Enugu State, Nigeria
*
Author to whom correspondence should be addressed.
Molecules 2011, 16(9), 7415-7427; https://doi.org/10.3390/molecules16097415
Submission received: 2 August 2011 / Revised: 24 August 2011 / Accepted: 29 August 2011 / Published: 31 August 2011

Abstract

:
Tamarindus indica is widely used as a food and beverage and in traditional medicine. The apparent lack of dose standardization in herbal medicine necessitates the evaluation of the lethality T. indica on Artemia salina nauplii and chicken embryos via in vitro and in vivo techniques. Furthermore, hepatotoxicokinetics of the crude extract and fractions on Wister rats was also assessed. At concentrations of 200, 20 and 2 µg/mL, crude extract and fractions showed brine shrimp death percentages ranging from 86.70% to 3.30% and the sub-fractions showed death percentage ranges of 46.70% to 3.30%. Calculated LD50 values ranged from 832 µg/mL to 5,019 µg/mL. Dosing Wister rats with 25% and 50% concentration of LD50 determined for crude extract and fractions on chicken embryos showed an elevation in the ALT and AST levels in the serum. Brine shrimps and chicken embryos showed a positive correlation, with R2 values of 0.541 and 0.588 (P ≤ 0.05) for fractions and subfractions, respectively, as media for the lethality assay. Dose standardization in folk herbal medicine is imperative as T. indica used as food and medicine has been shown to be toxic at high doses. Brine shrimp and chicken embryos may be comparably used as medium for toxicity assay.

1. Introduction

Herbal medicine, a component of ethno-medicine, is as old as the history of man and spans all cultures [1,2]. The curative properties of herbs lie, incidentally, on secondary metabolites with in situ functions: toxins as deterrents to predation, pheromones attract insects for pollination, phytoalexins protect against bacterial and fungal attacks and allelochemicals which inhibit rival plants [3]. The development of pharmaceuticals favoured synthetic drugs and gave rise to the dominance of Western medicine; however, the observed toxicity of the latter and phenomenal emergence of strains resistant to antibiotics, for example, has warranted a return to or resurgence of herbal medicines in developed economies [4,5,6,7,8,9].
Tamarindus indica, an evergreen tree of the family Leguminoseae, has been used as both food and medicine, however it is often difficult to determine which use is more important [10,11,12]. Food uses include applications as a seasoning and as an ingredient in chutneys, curries, sauces, confections and beverages, as in some parts of the tropics, including Guatemala, Mexico and Puerto Rico, where commercially available beverage drinks, for example, Tamarind ade (trade name) have tamarind as the major ingredient [10]. As a medicine T. indica has been used as poultices for swollen joints, sprains and boils. Lotions made from it are used in treating conjunctivitis, as antiseptics, as vermifuges, treatments for dysentery, jaundice, erysipelas, hemorrhoids and various other ailments [12]. The bark of the tree is regarded as an effective astringent, tonic and febrifuge. Decoctions made from the fruit pulp is given as a remedy for indigestion, colic, gingivitis, asthma and eye inflammations; and lotions and poultices made from the bark are applied on open sores and caterpillar rashes. The powdered seeds are made into a paste for drawing boils and, with or without cumin seeds and palm sugar, are prescribed for chronic diarrhoea and dysentery [11,13,14]. T. indica has been empirically shown to have antibacterial activity [15,16].
Despite the numerous reports on the uses of T. indica, empirical documentation on its toxicity is scarce and those available do not account for its effects on hepatocytes, which is the primary target organ for drug metabolism, upon prolonged administration. This study is deemed necessary due to the vast range of applications of T. indica in folklore and mythical conceptions of herbal/natural products’ non toxicity [17]. Moreover, herbal medicine has additional limitations which includes; lack of standardization [18,19], inadequate knowledge on the role of all the active principles individually or in combination, and the implications of prolonged use [20,21]. Hence, the need for this study which aims at assessing acute toxicity of T. indica stem bark crude extract and fractions on Artemia salina nauplii (brine shrimps) and chicken embryos with subsequent evaluation of the hepatotoxic effects on Wister rats.

2. Results

2.1. Extraction and Fractionation of Extract

Column chromatographic fractionation of ethanol extract of T. indica stem bark yielded six fractions viz. TiA, TiB, TiC, TiD, TiE and TiF. TiA eluted first and TiF eluted last and each showed a single band on TLC, whereas TiB, TiC, TiD and TiE showed five, three, two and two bands, respectively. On refractionation of the fractions with multiple bands TiB yielded four distinct fractions, each expressing a single TLC band. These were designated B1, B2, B3 and B4, while TiC, TiD and TiE yielded two fractions each, that were similarly designated C1 and C2, D1 and D2, E1 and E2, respectively (Table 1). We have previously reported the phytoconstituents of fractions TiA–TiF, sub-fractions B1–B4; C1, C2; D1, D2; E1 and E2, and their antibacterial activities [15,16].

2.2. Brine Shrimp Lethality

Lethality assessment of T. indica crude extract and fractions on brine shrimps (nauplii) resulted in 70% (200 µg/mL) and 10% (20 µg/mL) nauplii death with crude extract (Table 2).
Similarly, at concentrations of 200, 20 and 2 (µg/mL), the range of percentages of lethality shown by the fractions TiA–TiF was 86.7% (TiE; 200 µg/mL) to 3.3% (TiC; 200 µg/mL). The calculated 50 percent lethal dose (LD50) for the crude extract is 1,542 µg/mL, while that of the fractions; TiA, TiB, TiC, TiD, TiE and TiF were 832, 2,753, 3,332, 1,626, 2,949 and 3,183 (µg/mL), respectively. Similarly, sub-fractions B1, B2, B3 and B4 showed 2,596, 3,980, 6,004 and 2,745 (µg/mL) as their respective 50% lethal dose (LD50) while C1 and C2 each yielded 3,183 µg/mL. Lastly, D1, D2, E1, and E2 showed 3,332, 1,717, 3,332, and 2,083 (µg/mL) as their respective LD50 values (Table 3).

2.3. Chicken Embryo Lethality

Alternative use of chicken embryos for toxicity assessment of T. indica crude ethanol extract and fractions via inoculation of 250, 25 and 2.5 (mg/mL) of crude extract and fractions into viable 10-day old pre-incubated embryonated chicken eggs with subsequent reincubation showed the following results: At 250 mg/mL for both crude ethanol extract and initial fractionation products (TiA, TiB, TiC, TiD, TiE and TiF), death percentages ranged 13.4 to 46.6, while at 25 mg/mL death percentages ranged from 34.4 to 13.4, respectively. The crude ethanol extract yielded an LD50 of 2,720, while TiA, TiB, TiC, TiD, TiE and TiF yielded 2,484, 5,019, 2,910, 4,344, 2,526 and 3,174, respectively (Table 4).
Similarly, the sub-fractions, at 250 mg/mL, killed chicken embryos with a percentage range of 6.6 to 40, while at 25 mg/mL, 6.6% to 33.4% deaths was observed. The calculated LD50s for these sub-fractions were; 2,720 (B1), 2,997 (B2), 4,483 (B3), 4,344 (B4), 3,312 (C1), 3,174 (C2), 3,132 (D1 and D2 each), 2,995 (E1) and 2,997 (E2), respectively (Table 5).

2.4. Correlation Analysis of Lethality Assay Media

Regression analysis of the LD50 values obtained with T. indica fractions TiA–TiF and subfractions B1–B4, C1, C2, D1, D2, E1 and E2 on brine shrimp nauplii and chicken embryos, for measurement of similarity as media for lethality assay, showed a positive correlation. The proximity matrix showed an association coefficient (R2 value) of 0.541 at P ≤ 0.05 against fractions TiA–TiF (Table 6), while sub-fractions; B1–B4, C1, C2, D1, D2, E1 and E2 similarly showed a linear association coefficient (R2 value) of 0.588 at P ≤ 0.05 (Table 7).

2.5. Hepatotoxicokinetics

Dosing Wister rats with T. inica crude extract and fractions at 25% and 50% concentrations of pre-determined LD50 on chicken embryos, showed an elevation in the AST and ALT levels in the serum. The ranges of AST levels after administering 25% concentration of extract and fractions were (U/L); 19.6 ± 3.2–35.7 ± 2.2 (crude extract), 23.6 ± 2.7–39.7 ± 1.9 (TiA), 24.5 ± 2.1–33.4 ± 2.7 (TiB), 18.2 ± 1.3–26.4 ± 3.5 (TiC), 23.6 ± 1.9–30.4 ± 3.3 (TiD), 22.6 ± 3.4–41.2 ± 2.7 (TiE) and 23.6 ± 1.1–31.9 ± 2.5 (TiF) respectively. Dose concentration increase to 50% LD50 resulted in further elevation in the serum AST levels (Table 8), with the following ranges (U/L); 36.2 ± 4.1–64.2 ± 2.2 (crude extract), 46.7 ± 5.1–69.2 ± 6.6 (TiA), 39.5 ± 3.0–63.0 ± 7.5 (TiB), 31.0 ± 2.5–57.4 ± 1.8 (TiC), 38.2 ± 3.8–57.1 ± 5.2 (TiD), 48.4 ± 3.1–80.0 ± 3.5 (TiE) and 39.6 ± 0.8–57.2 ± 0.5 (TiF) respectively. Similarly, dosing with 25% concentration of LD50 showed ranges of serum ALT levels as follows (U/L); 24.0 ± 1.1–37.5 ± 2.4 (crude extract), 28.4 ± 1.3–39.4 ± 2.7 (TiA), 25.4 ± 0.7–39.1± 1.4 (TiB), 18.7 ±2.1–35.3 ± 1.3 (TiC), 21.5 ± 2.5–38.3 ± 1.8 (TiD), 24.9 ± 1.4–39.2 ± 3.3 (TiE) and 22.7 ± 2.4–41.9 ± 1.6 (TiF) respectively. However, dose concentration increase to 50% LD50 similarly resulted in the elevation of serum ALT levels (Table 9). The ranges were (U/L); 46.9 ± 2.3–68.0 ± 1.3 (crude extract), 52.6 ± 3.3–71.2 ± 3.4 (TiA), 46.2 ± 2.3–68.9 ± 1.4 (TiB), 41.5 ± 1.7–61.5 ± 1.9 (TiC), 38.2 ± 2.6–67.8 ± 2.8 (TiD), 45.8 ± 1.2–61.9 ± 1.8 (TiE) and 39.5 ± 0.9–59.9 ± 1.7 (TiF) respectively. The peak of AST and ALT elevations at 25 and 50 (%) concentration were between the ranges of 12 to 18 days on the average.

3. Discussion

3.1. Lethality Assays

The shrimp lethality assay proposed by Michael et al. [22] and later developed by Vanhaecke et al. [23] and Sleet and Brendel [24] is based on the ability of test agents to kill laboratory cultured Artemia salina nauplii (brine shrimp). The assay is considered a useful tool for preliminary assessment for toxicity [25], and it has been used for the detection of fungal toxins, plant extract toxicity or pharmacological activities and testing of dental material cytotoxicity, among others [26,27,28]. At 200 µg/mL concentration, TiE and TiA both killed 86.7% and 80.0% of the brine shrimps, which is higher than the result obtained with the crude extract (70%). This falls in line with the work of Dong et al. [29] where herbal extract purification increased toxicity. However, TiC, TiD and TiF showed results which were to the contrary. TiC showed the least toxicity even though it presented good bioactivity [15]. The results obtained in this research shows that herbal purification may yield products with higher or reduced toxicity when compared to the crude extract. In addition to high concentration playing major role in toxicity [30], the nature of bioactive constituent is similarly crucial as different compounds pose varied toxicity. Potency of bioactive compounds may not necessarily have a direct relationship with toxicity as we observed with fraction TiC. Chicken embryo toxicity showed result patterns somewhat similar to those obtained with brine shrimps.

3.2. Proximity Matrix Construct for Measure of Similarity between Assay Media

Proposed media for cytotoxicity assays include brine shrimps, chicken embryos, whole animals (guinea pigs and Wister rat) and plants. However, brine shrimp enjoys more usage as the assay is cheap and fast. In addition, the increased recognition of animal rights will continue to place brine shrimp as an indispensable tool for toxicity testing. A chicken embryo has not enjoyed the same status as brine shrimps, even though it is proposed as a similar tool. However, lethality testing using both assay media and analyzing the results obtained thereof, for measure of similarity between the assay medium indicated a positive correlation. The use of brine shrimps and chicken embryos showed 60% similarity; consequently this result may be interpreted to mean that chicken embryo could serve in the determination of LD50, but not in place of the brine shrimps and vice versa as the variation in sensitivity is large.

3.3. Hepatotoxicokinetics

Dosing Wister rats with 25% and 50% LD50 concentrations of crude extract and fractions showed a time dependent elevation in liver enzymes (ALT and AST) in the serum. At 25% LD50 concentration, serum ALT steadily increased over time and peaked at day 12 for TiA, TiD and TiF. Others showed peak values at 15 and 18 days, respectively. At an increased dose (50% LD50), a different pattern was observed as some fractions showed peak ALT values at different days from the former: crude extract (day 15), TiA (day 18) and TiC (day 12). Serum AST levels followed a similar pattern as ALT, thus showing variations in peak time with concentration for different fractions. The elevations in serum ALT and AST levels are associated with hepatocellular injury [31], and these were observed with Wister rats when dosed with sub-lethal doses (25% and 50%) of T. indica. However, only 50% LD50 concentrations were able to elicit serum liver enzymes with values above the normal threshold for healthy hepatocytes (AST; 5–34 U/L and ALT; 7–56 U/L). ALT and AST are released from damaged hepatocytes into the blood following hepatocellular injury or death, although they can originate from other tissues. However, elevation of ALT and AST that is the five times higher than the normal and over range has been used as a paradigm in the classifications of liver disease states [31]. The AST and ALT levels observed in this study are nowhere near the values that signify a disease stated, but this gives an insight on what may occur if a lethal dose of T. indica is administered to the experimental animals. The patterns to which the liver enzymes peak over time with subsequent stabilization or decline may suggest acclimatization to the toxicants.

4. Experimental Section

4.1. Plant Materials

The stem bark of the study plant was obtained from the woods of More in Sokoto South Local Government Area, Sokoto State, Nigeria. The plant was identified taxonomically and a voucher specimen deposited at the Herbarium of the Department of Botany, University of Nigeria, Nsukka.

4.2. Extractions of the Plant Materials

Fresh stem bark of T. indica were rinsed thoroughly in running tap water, chopped to tiny pieces and air dried at room temperature (~27 °C). The dried stem bark was pulverised and 50 g of the milled material was macerated in absolute ethanol (Sigma-Aldrich, 200 mL) and left to stand for about 4 h. The preparation was filtered through Whatman No. 1 filter paper and the filtrate concentrated to dryness under a steady air current. The extract was stored in sterile containers at a temperature of 4 °C until use.

4.3. Fractionation of Extract

The ethanol extract of the stem bark of T. indica were re-constituted in absolute ethanol and spotted on analytical TLC plates (silica gel G600; 0.25 mm thickness) and ethanol/ethyl acetate 6:4 systems showed better separation of the spotted extract. Fractionation and re-fractionation of the extracts were carried out using standard methods [15].

4.4. Brine Shrimp Lethality Assay

The brine shrimp lethality bioassay technique was as described by Meyer et al. [32] and McLaughlin et al. [27]. The Artemia salina (Leach) eggs (Interpet Ltd., Dorking, UK) were obtained from the Veterinary Pharmacology Department, University of Nigeria, Nsukka. To natural seawater obtained from the Atlantic Ocean at Bar Beach Lagos, Nigeria (about 200 mL), Artemia salina eggs (20 mg) were added and incubated at room temperature (~27 °C) for about 48 h in a hatchery. Brine shrimp larvae (nauplii) were separated from the eggs by picking with a Pasteur pipette into small beakers containing seawater. Three sets of 10 Artemia salina nauplii were, each, exposed to 200, 20 and 2 µg/mL of crude stem bark extract and its fractions in sea water. This was done in triplicate and the shrimp were then incubated at room temperature (~27 °C) for about 24 h after which surviving shrimps of each treatment was recorded and the lethal dose that killed 50% of the shrimps (LD50) determined by regression analysis.

4.5. Chicken Embryo for Lethality Assay

Embryonated chicken eggs (53 ± 0.6 g) were obtained from the intensive reared poultry of the Virology Unit, Department of Microbiology, University of Nigeria, Nsukka. Egg incubation was within five days of lay, in a humidified incubator at 37 °C for 9–10 days with candling and manual turning, thrice daily. Unfertilized eggs and eggs with dead embryos were discarded.

4.6. Chicken Embryo Lethality Assay

Three sets of five ten-day old embryonated chicken eggs were, each, inoculated with a single dose (100 µL) of 250, 125 or 62.5 mg/mL of the crude stem bark extract following standard procedures [33]. The eggs were incubated in a humidified incubator, turned thrice daily and candled once every 24 h to assess the viability of the chick embryo; eggs were discarded if embryo death occurred within 24 h [34] and beyond, death was recorded. Similar procedure was repeated with all the chromatographic fractions obtained. The control groups were inoculated with sterile distilled water and incubated in the same conditions as the treatment groups.

4.7. Animal Study

Sixty-four healthy male Wister rats aged three weeks were purchased from the Animal Unit, Department of Veterinary Parasitology, University of Nigeria, Nsukka. The rats were reared in metabolic cages at room temperature (~27 °C), relative humidity 47 ± 5% and 12 h light/dark cycle at the animal house, Virology Unit, Department of Microbiology, University of Nigeria, Nsukka. Commercial pellet feed (Guinea feeds) and water was available ad libitum. After five weeks of breeding, each rat weighed 150–180 g on the average. The rats were randomly placed into 16 homogenous weight groups with four rats in each group. The first seven groups were dosed with 25% LD50 concentration (LD50 pre-determined on chicken embryo; Section 2.6) of crude and the six fractions (TiA–TiF) while the second seven groups were similarly dosed with 50% LD50 and the controls received distilled water. At 25% LD50, dose translates to the following concentrations (mg/mL); 680 (crude extract), 621(TiA), 1,255 (TiB), 730 (TiC), 1,086 (TiD), 632 (TiE) and 794 (TiF) while 50% LD50 similarly translates to (mg/mL); 1,360 (crude extract), 1,242 (TiA), 2,510 (TiB), 1,460 (TiC), 2,172 (TiD), 1,263 (TiE) and 1,587 (TiF), respectively. The solvent for reconstitution was sterile distilled water and crude extract and fractions (200 µL) were administered orally per 20 g of body weight routinely at 24 h intervals for 21 days. At 72 h (three days) interval the rats were bled via ocular puncture, and blood samples were allowed to clot and serum separated by centrifugation (3,000 rpm; 5 min). Animal studies where in compliance to the ethical procedure of the Animal Use and Care Committee, Faculty of Veterinary Medicine, University of Nigeria, Nsukka which corresponds with NIH guidelines [35].

4.8. Liver Enzyme Assay-Aspartate Aminotransferase and Alanine Aminotransferase

Aspartate aminotransferase (AST) levels in each serum sample were determined using AST reagent kits (Ouimica Clinica Aplicada, Amposta, Spain). The AST reagents consisted of phosphate buffer (100 mM) pH 7.4, α-ketoglutaric acid (2 mM) and L-aspartic acid (100 mM) contained in 100 mL of substrate solution. Other reagents used include a colour developer (1 mM of 2,4-dinitrophenyl-hydrazine [DNPH]) and 4N NaOH which was diluted (1/10) with deionised water). The assays were conducted according to the manufacturers’ instruction protocol. Thus, AST substrate (500 µL) was pipetted into a test tube and incubated in a water bath for 5 min at 37 °C after which serum (100 µL) was added with further incubated for 30 min at the same temperature. Afterwards, DNPH (500 µL) was added and held at room temperature (~27) for 20 min followed by addition of dilute NaOH (0.4 N, 5000 µL) with further incubation for 15 min. The absorbance as measured by optical density (OD) was read using a colorimeter (EI, Yong Jing, China) at 505 nm wavelength against blank. The ALT reagent was likewise composed of phosphate buffer, pH 7.4 (100 mL), α-ketoglutaric acid (2 mM) and L-alanine (100 mM) in 100 mL of substrate solution. The same colour developer, NaOH (0.4 N) and assay protocol was used as in AST assay.

4.9. Statistical Analysis

Brine shrimp and chicken embryo lethality was calculated using Probit analysis, while analysis of variance (ANOVA) was used to analyze aspartate aminotransferase and alanine aminotransferase levels obtained in the hepatotoxic assay on Wister rats. The statistic package used for the analysis is SPSS for windows version 17 (SPSS Inc., Chicago, IL, USA).

5. Conclusions

This study shows that brine shrimps and chicken embryos are not comparable media in cytotoxicity assays and the variation in sensitivity may be attributed to genetic variability among other factors. However, the positive association obtained between these assay media implies that both media could be used in cytotoxicity testing of bioactive compounds. The assertion that “the dose makes the poison” holds true as T. indica, the plant, with vast applications in food, beverages, and folk medicine, among others, has been shown to be intrinsically hazardous, at high doses, like all chemical agents. The abnormal serum liver chemistry obtained in this study has shown some insight into the mechanism of toxicity of T. indica, this is necessary because there is a paucity of information on herbal toxicity and more so their effects on the hepatocytes which is where detoxification and drug metabolism, among other processes, take place. Hence, toxic responses obtained with laboratory animals will predicate responses in humans at high doses over time.

Acknowledgement

The authors are grateful to the Govan Mbeki Research and Development Centre (GMRDC) of the University of Fort Hare, Alice, South Africa, for the facilities used in the course of preparing this manuscript. We are also thankful to E.C. Nwodo of the Department of English, Shehu Shagari College of Education, Sokoto, Nigeria for her technical support.

Conflict of Interest Statement

The authors declare that there are no conflicts of interest.

References and Notes

  1. Thomson, W.A.R. Medicines from the Earth; McGraw-Hill Book, Co.: Maidenhead, UK, 1978. [Google Scholar]
  2. Stockwell, C. Nature’s Pharmacy; Century Hutchinson Ltd.: London, UK, 1988. [Google Scholar]
  3. Marjorie, M.C. Plant products as antimicrobial agents. Clin. Microbiol. Rev. 1999, 12, 564–582. [Google Scholar]
  4. MacLennan, A.H.; Wilson, D.H.; Taylor, A.W. Prevalence and cost of alternative medicine in Australia. Lancet 1996, 347, 569–573. [Google Scholar] [CrossRef]
  5. Bateman, J.; Chapman, D.; Simpson, D. Possible toxicity of herbal remedies. Scot. Med. J. 1998, 43, 7–15. [Google Scholar] [CrossRef] [PubMed]
  6. Sibbald, B. New federal office will spend millions to regulate herbal remedies vitamins. CMAJ 1999, 160, 1355–1357. [Google Scholar] [PubMed]
  7. Chang, J. Medicinal herbs: Drugs or dietary supplements? Biochem. Pharm. 2000, 59, 211–219. [Google Scholar] [CrossRef]
  8. Harris, P.; Rees, R. The prevalence of complementary and alternative medicine use among the general population: A systematic review of the literature. Complement. Ther. Med. 2000, 8, 88–96. [Google Scholar] [CrossRef] [PubMed]
  9. Popat, A.; Shear, N.H.; Malkiewicz, I.; Stewart, M.J.; Steenkamp, V.; Thomson, S.; Neuman, M.G. The toxicity of Callilepis laureola, a South African traditional herbal medicine. Clin. Biochem. 2001, 34, 229–236. [Google Scholar] [CrossRef]
  10. Anon, B. The Useful Plants of India; CSIR: New Delhi, India, 1986. [Google Scholar]
  11. Morton, J. Tamarind In: Fruits of Warm Climates; Creative Resources Systems, Inc.: Miami, FL, USA, 1987; pp. 115–121. [Google Scholar]
  12. Pamploma-Roger, G.D. Encyclopaedia of Medicinal Plants; Education and Health Library: Madrid, Spain, 1999; Volume 2, p. 536. [Google Scholar]
  13. Popenoe, W. Manual of Tropical and Subtropical Fruits; Hafner Press: New York, NY, USA, 1974; pp. 225–269. [Google Scholar]
  14. Raimondi, L.; Lodovici, M.; Guglielmi, F.; Banchelli, G.; Ciuffi, M.; Boldrini, E.; Pirisino, R. The polysaccharide from Tamarindus indica (TS-polysaccharide) protects cultured corneal-derived cells (SIRC cells) from ultraviolet rays. J. Pharm. Pharmacol. 2003, 55, 333–338. [Google Scholar] [CrossRef] [PubMed]
  15. Nwodo, U.U.; Ngene, A.A.; Iroegbu, C.U.; Obiiyeke, G.C. Effects of fractionation on antibacterial activity of crude extracts of Tamarindus indica. Afr. J. Biotechnol. 2010, 9, 7108–7113. [Google Scholar]
  16. Nwodo, U.U.; Iroegbu, C.U.; Ngene, A.A.; Chigor, V.N.; Okoh, A.I. Effects of fractionation and combinatorial evaluation of tamarindus indica fractions for antibacterial activity. Molecules 2011, 16, 4818–4827. [Google Scholar] [CrossRef] [PubMed]
  17. Stickel, F.; Egerer, G.; Seitz, H.K. Hepatotoxicity of botanicals. Publ. Health Nut. 2000, 3, 113–124. [Google Scholar] [CrossRef]
  18. Angell, M.; Kassierr, J.P. Alternative medicine—The risk of untested and unregulated remedies. N. Engl. J. Med. 1998, 339, 839–841. [Google Scholar] [CrossRef] [PubMed]
  19. NIEHS. News: Herbal health. Environ. Health Perspect. 1998, 106, A590–A592. [Google Scholar] [CrossRef]
  20. Miller, L.G. Herbal medicinal: Selected clinical considerations focusing on known or potential drug—Herb interactions. Arch. Intern. Med. 1998, 158, 200–211. [Google Scholar] [CrossRef]
  21. Matthews, H.B.; Lucier, G.W.; Fisher, K.D. Medicinal herbs in the United States: Research needs. Environ. Health Perspect. 1999, 107, 773–778. [Google Scholar] [CrossRef] [PubMed]
  22. Michael, A.S.; Thompson, C.G.; Abramovitz, M. Artemia salina as a test organism for a bioassay. Science 1956, 123, 464. [Google Scholar] [CrossRef] [PubMed]
  23. Vanhaecke, P.; Persoone, G.; Claus, C.; Sorgeloos, P. Proposal for a short-term toxicity test with Artemia nauplii. Ecotoxicol. Environ. Safety 1981, 5, 382–387. [Google Scholar] [CrossRef]
  24. Sleet, R.B.; Brendel, K. Improved methods for harvesting and counting synchronous populations of Artemia nauplii for use in developmental toxicology. Ecotoxicol. Environ. Safety 1983, 7, 435–446. [Google Scholar] [CrossRef]
  25. Solís, P.N.; Wright, C.W.; Anderson, M.M.; Gupta, M.P.; Phillipson, J.D. A microwell cytotoxicity assay using Artemia salina. Plant Med. 1993, 59, 250–252. [Google Scholar] [CrossRef] [PubMed]
  26. Harwig, J.; Scott, P. Brine shrimp (Artemia salina L.) larvae as a screening system for fungal toxins. Appl. Microbiol. 1971, 21, 1011–1016. [Google Scholar] [PubMed]
  27. McLaughlin, J.L.; Cheng, C.; Smith, D.L. Bench-top bioassays for discovery of bioactive natural products: An update. Stud. Nat. Prod. Chem. 1991, 9, 383–409. [Google Scholar]
  28. Pelka, M.; Danzl, C.; Distler, W.; Petschelt, A. A new screening test toxicity testing of dental materials. J. Dentistry 2000, 28, 341–345. [Google Scholar] [CrossRef]
  29. Dong, L.I.U.; Zhanguo, G.A.O.; Jian, Z.; Jianping, Y.E.; Zhijun, L.I.U. Bioassay-guided fractionation of Rubus suavissimus leaf extracts possessing NF-κB inhibitory activities and a separable cytotoxicity. Pharm. Biol. 2005, 43, 713–717. [Google Scholar]
  30. Hugo, W.B.; Russell, A.D. Pharmaceutical Microbiology; Blackwell Science Ltd.: Oxford, UK, 1992. [Google Scholar]
  31. Green, R.M.; Flamm, S. AGA technical review on the evaluation of liver chemistry tests. Gastroenterology 2002, 123, 1367–1384. [Google Scholar] [CrossRef] [PubMed]
  32. Meyer, B.N.; Ferrigni, N.R.; Putman, J.E.; Jacobson, L.B.; Nichols, D.E.; Mclaughlin, J.I. Brine shrimps: A convenient general bioassay for active plant constituents. Planta Med. 1982, 45, 31–34. [Google Scholar] [CrossRef] [PubMed]
  33. Nwodo, U.U.; Ngene, A.A.; Iroegbu, C.U.; Onyedikachi, O.A.L.; Chigor, V.N.; Okoh, A.I. In vivo evaluation of the antiviral activity of Cajanus cajan on measles virus. Arch. Virol. 2011. [Google Scholar] [CrossRef] [PubMed]
  34. OIE. Newcastle Disease. Manual of Standard for Diagnostic Tests and Vaccines; Office International des Epizootics: Paris, France, 2004; pp. 221–232. [Google Scholar]
  35. NIH. Guide for the Care and Use of Laboratory Animals; National Academy Press: Washington, DC, USA, 1996. [Google Scholar]
Sample Availability: Samples of the compounds are available from the authors.
Table 1. Chromatographic separations of the stem bark of Tamarindus indica.
Table 1. Chromatographic separations of the stem bark of Tamarindus indica.
Products of first fractionationTracks on TLCRefractionation products Tracks on TLC
Crude EOH extract of stem barkTiA
TiB
TiC
TiD
TiE
TiF
1
5
3
2
2
1
-
B1, B2, B3, and B4
C1 and C2
D1 and D2
E1 and E2
-
-
1
1
1
1
-
Table 21. Lethality of T. indica fractions on Brine shrimp.
Table 21. Lethality of T. indica fractions on Brine shrimp.
FractionsConcentrations/Death rate (%)
200 ppm20 ppm2 ppmLD50
Crude70.010.00.01542
TiA80.046.7013.30832
TiB26.703.300.02753
TiC3.300.00.03332
TiD23.303.300.02950
TiE86.700.00.01626
TiF23.306.700.03183
Table 3. Lethality of T. indica sub-fractions on Brine shrimp.
Table 3. Lethality of T. indica sub-fractions on Brine shrimp.
Sub-fractionsConcentrations/Death rate (%)
200 ppm20 ppm2 ppmLD50
B130.03.300.02596
B216.706.700.03980
B310.06.700.06004
B410.00.00.02745
C13.300.00.03332
C23.300.00.03332
D123.306.700.03183
D23.300.00.03332
E160.013.300.01717
E246.7013.300.02083
Table 4. Lethality of T. indica fractions on chicken embryo.
Table 4. Lethality of T. indica fractions on chicken embryo.
Sub-fractionsConcentrations/Death rate (%)
250 mg/mL25 mg/mL2.50 mg/mLLD50
Crude40.013.400.02720
TiA46.6033.406.602484
TiB13.4013.400.05019
TiC13.400.00.02920
TiD13.406.600.04344
TiE46.600.00.02526
TiF26.606.600.03174
Table 5. Lethality of T. indica sub-fractions on chicken embryo.
Table 5. Lethality of T. indica sub-fractions on chicken embryo.
Sub-fractionsConcentrations/Death rate (%)
250 mg/mL25 mg/mL2.50 mg/mLLD50
B140.013.400.02720
B233.4026.670.02997
B333.4026.6020.04483
B433.406.600.04344
C126.6013.400.03312
C226.606.600.03174
D16.600.00.03132
D26.600.00.03132
E133.4033.400.02995
E233.4026.600.02997
Table 6. Proximity matrix of Artemia salina nauplii and chicken embryos calculated from LD50 yield of T. indica fractions.
Table 6. Proximity matrix of Artemia salina nauplii and chicken embryos calculated from LD50 yield of T. indica fractions.
Tool used to determine LD50Correlation between vectors of values
Artemia salina naupliiEmbryonated chicken eggs
Artemia salina nauplii
Embryonated chicken eggs
1.000
0.541
0.541
1.000
P = 0.05.
Table 7. Proximity matrix of Artemia salina nauplii and chicken embryos calculated from LD50 yield of T. indica refractionations.
Table 7. Proximity matrix of Artemia salina nauplii and chicken embryos calculated from LD50 yield of T. indica refractionations.
Tool used to determine LD50Correlation between vectors of values
Artemia salina naupliiEmbryonated chicken eggs
Artemia salina nauplii
Embryonated chicken eggs
1.000
0.588
0.588
1.000
P = 0.05.
Table 8. Aspartate aminotransferase concentration at T. indica dosage over time.
Table 8. Aspartate aminotransferase concentration at T. indica dosage over time.
DaysCrudeTiATiBTiCTiDTiETiFControl
25% Concentration of Extract and fractions (mg/20 g body weight)/AST levels (U/L)
319.6 ± 3.223.6 ± 2.724.5 ± 2.118.2 ± 1.323.6 ± 1.922.6 ± 3.423.0 ± 1.117.3 ± 1.7
624.5 ± 4.629.1 ± 4.426.9 ± 3.120.8 ± 2.325.6 ± 2.129.1 ± 1.925.0 ± 1.819.6 ± 2.0
927.6 ± 6.233.5 ± 6.331.8 ± 1.822.2 ± 1.928.7 ± 3.936.5 ± 2.029.4 ± 1.919.9 ± 1.5
1233.5 ± 2.939.7 ± 1.932.6 ± 1.725.0 ± 3.130.4 ± 3.340.5 ± 3.931.9 ± 2.520.2 ± 1.9
1534.8 ± 1.839.1 ± 3.133.3 ± 2.426.2 ± 2.229.4 ± 1.541.2 ± 2.731.4 ± 1.918.9 ± 1.7
1835.7 ± 2.237.8 ± 2.033.3 ± 1.626.4 ± 3.529.1 ± 0.940.8 ± 1.730.9 ± 1.418.2 ± 2.1
2135.0 ± 3.137.4 ± 2.833.4± 2.725.9 ± 2.028.3 ± 1.138.9 ± 1.330.2 ± 0.918.7 ± 1.8
50% Concentration of Extract and fractions (mg/20 g body weight)/AST levels (U/L)
336.2 ± 4.146.7± 5.139.5 ±3.031.0 ± 2.538.2 ± 3.848.4 ± 3.139.6 ± 0.817.3 ± 1.7
641.7 ± 3.952.3 ± 7.249.1 ± 4.448.6 ± 3.148.7 ± 2.953.9 ± 3.743.7 ± 2.319.6 ± 2.0
958.9 ± 5.257.8 ± 4.257.5 ± 2.953.2 ± 2.754.5 ± 1.965.0 ± 2.749.7 ± 1.919.9 ± 1.5
1261.6 ± 3.162.1 ± 8.163.0 ± 7.657.4 ± 1.857.1 ± 5.271.2 ± 4.257.2 ± 0.516.8 ± 1.9
1564.2 ± 2.268.3 ± 5.358.3 ± 4.946.9 ± 4.153.1 ± 5.377.6 ± 5.251.4 ± 2.618.9 ± 1.7
1861.9 ± 1.969.2 ± 6.655.8 ± 2.542.5 ± 2.249.3 ± 3.380.0 ± 3.545.2 ± 3.216.8 ± 2.1
2159.7 ± 1.367.2 ± 5.954.6 ± 1.838.9 ± 3.944.6 ± 2.580.0 ± 2.241.5 ± 1.819.5 ± 1.8
Normal range of AST value for healthy animals 5–34 U/L.
Table 9. Alanine aminotransferase concentration at T. indica dosage over time.
Table 9. Alanine aminotransferase concentration at T. indica dosage over time.
DaysCrudeTiATiBTiCTiDTiETiFControl
25% Concentration of Extract and fractions (mg/20g body weight)/ALT levels (U/L)
324.0 ± 1.128.4 ± 1.325.4 ± 0.718.7 ± 2.121.5 ± 2.524.9 ± 1.422.7 ± 2.418.6 ± 1.3
627.1 ± 1.732.5 ± 2.626.9 ± 1.121.6 ± 1.627.2 ± 1.229.4 ± 1.725.2 ± 1.520.3 ± 2.7
931.9 ± 2.337.2 ± 1.833.2 ± 2.329.6 ± 1.438.3 ± 1.837.1 ± 1.833.7 ± 1.719.7 ± 1.8
1234.6 ± 1.739.4 ± 2.739.1 ± 1.435.1 ± 2.235.4 ± 2.439.2 ± 3.341.9 ± 1.619.2 ± 1.5
1537.5 ± 2.436.0 ± 3.538.0 ± 3.135.3 ± 1.329.6 ± 1.636.1 ± 1.735.9 ± 2.419.2 ± 1.7
1835.1 ± 1.234.7 ± 1.835.2 ± 1.233.1 ± 2.724.6 ± 1.130.2 ± 1.632.7 ± 3.120.3 ± 1.9
2134.9 ± 1.932.9 ± 2.330.3 ± 1.532.2 ± 1.324.1 ± 2.827.6 ± 1.530.5 ± 1.919.5 ± 1.5
50% Concentration of Extract and fractions (mg/20g body weight)/ALT levels (U/L)
346.9 ± 2.352.6 ± 3.346.2 ± 2.341.5 ± 1.738.2 ± 2.645.8 ± 1.239.5 ± 0.915.9 ± 1.3
658.2 ± 1.359.1 ± 2.753.1 ± 1.947.2 ± 0.946.7 ± 2.351.4 ± 1.543.8 ± 1.321.0 ± 2.7
962.4 ± 2.567.4 ± 1.561.8 ± 3.153.8 ± 2.158.2 ± 1.956.6 ± 2.659.9 ± 1.719.7 ± 1.8
1267.1 ± 2.271.2 ± 3.463.4 ± 2.857.9 ± 2.662.3 ± 3.161.9 ± 1.857.3 ± 2.819.2 ± 1.5
1568.0 ± 1.368.1 ± 2.668.9 ± 1.461.5 ± 1.967.8 ± 2.858.8 ± 2.154.1 ± 3.518.5 ± 1.7
1865.9 ± 1.566.3 ± 1.265.2 ± 1.754.7 ± 2.157.2 ± 1.950.9 ± 2.250.2 ± 2.323.0 ± 1.9
2166.3 ± 1.362.5 ± 2.760.9 ± 2.351.9 ± 1.554.1 ± 1.755.9 ± 1.443.2 ± 2.719.5 ± 1.5
Normal range of ALT value for healthy animals 7–56 U/L.

Share and Cite

MDPI and ACS Style

Nwodo, U.U.; Ngene, A.A.; Anaga, A.O.; Chigor, V.N.; Henrietta, I.I.; Okoh, A.I. Acute Toxicity and Hepatotoxicokinetic Studies of Tamarindus indica Extract. Molecules 2011, 16, 7415-7427. https://doi.org/10.3390/molecules16097415

AMA Style

Nwodo UU, Ngene AA, Anaga AO, Chigor VN, Henrietta II, Okoh AI. Acute Toxicity and Hepatotoxicokinetic Studies of Tamarindus indica Extract. Molecules. 2011; 16(9):7415-7427. https://doi.org/10.3390/molecules16097415

Chicago/Turabian Style

Nwodo, Uchechukwu U., Augustine A. Ngene, Aruh O. Anaga, Vincent N. Chigor, Igbinosa I. Henrietta, and Anthony I. Okoh. 2011. "Acute Toxicity and Hepatotoxicokinetic Studies of Tamarindus indica Extract" Molecules 16, no. 9: 7415-7427. https://doi.org/10.3390/molecules16097415

Article Metrics

Back to TopTop